Cancer Detecting Sensor Developed

Researchers in Japan develop cancer-detecting sensor

In the future, it may become possible for an individual to easily check their health by connecting a sensor to a smartphone or other device. There are also hopes the world’s growing medical expenditures could be curbed by the early detection of disease.

Now the Japan-based National Institute for Materials Science (NIMS) announced the development of a small sensor capable of detecting substances in a person’s exhalations with high accuracy by analyzing the odor of the breath.

To put this technology into practical use, the institute worked with Kyocera Corp., NEC Corp., Sumitomo Seika Chemicals Co., Osaka University and a precision equipment maker in Switzerland.

A “film” installed in the sensor, which is a tiny chip a few millimeters square, determines whether there are substances peculiar to cancer patients’ breath and calculates whether a person is suspected to have cancer. By just exhaling into the sensor, which is connected to a smartphone or other device, the result can be displayed on the screen of the device in a graph or other form.

NIMS reported the sensor is highly likely to distinguish what kind of cancer a person has if the sensor’s accuracy is improved and data on odor is collected.

Peculiar odors are said to be found in the respiration of patients who are suffering from diabetes, kidney and liver diseases, asthma, and those with Helicobacter pylori. The sensor may make it possible to judge what kind of diseases people have, and it is being considered for use not only for examinations at medical institutions but also for self-checks by individuals.

The sensor costs a few hundred yen — the equivalent of a few U.S. dollars — to make and can be produced in large quantities. It is expected to take about six years to develop for practical use in order to collect data on the odors associated with various cancers, improve the sensor’s precision and have it certified as medical equipment by the government, the developers noted.

Cancer is the leading cause of death among Japanese people, with nearly 400,000 people dying each year. According to a 2014 survey by the Cabinet Office, the medical examination rate for cancer screening in Japan is about 40 percent — about half that in the United States and some European nations.

Major reasons cited for not receiving cancer screening in the survey were having no time; the cost involved; and feeling uneasy about pain. Examinations of people’s exhalations would likely improve the medical examination rate. However, it still would be necessary for people to undergo further examinations at medical institutions to confirm whether they have a disease.

“It’ll be epoch-making if such a simple examination of exhalations becomes widely available,” said Nippon Medical School Professor Masao Miyashita, an expert on digestive surgery and cancer.